🔴 NeOnc Technologies Holdings is trading 11.95% down today; reason for decline remains unclear

NeOnc Technologies Holdings is trading 11.95% down at $3.83, with available coverage not identifying a clear reason for the decline.

• August 12, 2026, Phase 2a data for NEO100 showed positive results, including 48.9% six-month progression-free survival versus a 20% benchmark and no major toxicities.
• The decline follows a 24.29% gain to $4.35 on August 11, suggesting post-catalyst volatility or profit-taking.
• Broader markets are modestly higher, so macro sentiment does not explain the decline.